GlassScriptPhysician profile
Jan C Parrillo
NPI 1275500951
$8,695.53
in general payments reported to CMS, 2019-2025
59 companies · $887 in 2025
The $887 reported for 2025 was more than what 84% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,824 · 2020: $667 · 2021: $1,491 · 2022: $1,304 · 2023: $1,271 · 2024: $1,252 · 2025: $887.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,409.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,409.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,292.64 | 2019-2025 | Farxiga, Breztri, Airsupra |
| Novo Nordisk INC | $1,221.71 | 2019-2025 | Ozempic, Rybelsus |
| Tosoh Bioscience, INC. | $941.00 | 2019 | |
| Astellas Pharma US INC | $843.81 | 2019-2025 | Veozah, Myrbetriq |
| Lilly USA, LLC | $440.71 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Daiichi Sankyo INC. | $381.82 | 2020-2025 | Injectafer, Vanflyta |
| Pfizer INC. | $370.71 | 2019-2025 | |
| Abbvie INC. | $278.55 | 2021-2024 | |
| Esperion Therapeutics, INC. | $209.55 | 2020-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $184.05 | 2019-2025 | Xifaxan |
| Janssen Pharmaceuticals, INC | $173.10 | 2019-2024 | Spravato |
| Amgen INC. | $169.11 | 2019-2025 | Prolia, Evenity, Repatha |
| Merck Sharp & Dohme LLC | $148.43 | 2019-2024 | Gardasil, Capvaxive, Gardasil 9 |
| Kowa Pharmaceuticals America, INC. | $141.09 | 2021-2023 | Livalo |
| Takeda Pharmaceuticals U.S.A., INC. | $136.86 | 2021-2022 |
Show all 59 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceutical Holding Company LTD. | $122.98 | 2022 | |
| Glaxosmithkline, LLC. | $122.79 | 2019-2023 | Shingrix, Arexvy |
| Noven Therapeutics, LLC | $112.48 | 2023-2025 | Xelstrym |
| Boehringer Ingelheim Pharmaceuticals, INC. | $107.02 | 2019-2025 | Jardiance |
| Phathom Pharmaceuticals, INC. | $92.13 | 2023-2025 | Voquezna |
| Allergan, INC. | $86.13 | 2019-2020 | |
| Amarin Pharma, INC. | $83.22 | 2019-2022 | |
| Sanofi Pasteur INC. | $73.43 | 2019-2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $67.35 | 2024-2025 | |
| Exact Sciences Corporation | $58.58 | 2024-2025 | Cologuard Collection Kit |
| Vistapharm, INC. | $56.46 | 2021 | |
| Abbott Laboratories | $52.29 | 2023-2025 | Proclaim, Freestyle Libre 3 |
| Genentech USA, INC. | $48.29 | 2019-2020 | |
| Eisai INC. | $47.40 | 2020-2021 | |
| Sanofi-Aventis U.S. LLC | $43.41 | 2019 | |
| Renalytix Ai, INC. | $41.41 | 2023 | Kidneyintelx Blood Collection Convenience Kit |
| Xeris Pharmaceuticals, INC. | $35.71 | 2023 | Keveyis |
| Radius Health, INC. | $35.46 | 2019-2020 | |
| Scilex Pharmaceuticals INC. | $34.67 | 2023 | Ztlido |
| Averitas Pharma INC. | $28.71 | 2024 | Qutenza |
| Mylan Specialty L.P. | $28.19 | 2021-2022 | |
| Inspire Medical Systems, INC. | $27.22 | 2024 | Inspire |
| Silk Road Medical, INC. | $25.06 | 2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Biohaven Pharmaceuticals, INC. | $24.22 | 2021 | |
| Alk-Abello, INC | $22.06 | 2025 | Grastek, Odactra, Ragwitek |
| Jazz Pharmaceuticals INC. | $19.39 | 2020 | |
| Medtronic, INC. | $18.49 | 2025 | Inceptiv |
| Hikma Pharmaceuticals USA | $17.74 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $17.68 | 2021 | |
| Dynavax Technologies Corporation | $17.33 | 2023 | Heplisav-B |
| Ibsa Pharma INC. | $16.83 | 2023 | Licart, Tirosint |
| Shield Therapeutics INC | $16.39 | 2023 | Accrufer |
| Seqirus USA INC | $16.01 | 2020 | |
| Hologic Sales and Service, LLC | $15.71 | 2023 | Aptima, Thinprep 2000 Processor |
| Agios Pharmaceuticals, INC. | $14.92 | 2024 | |
| Noven Pharmaceuticals, INC. | $14.64 | 2023 | Xelstrym |
| Idorsia Pharmaceuticals US INC | $14.24 | 2023 | Quviviq |
| Gilead Sciences, INC. | $13.44 | 2019 | |
| Aytu Biopharma, INC. | $13.31 | 2019 | |
| Endo Pharmaceuticals INC. | $12.95 | 2023 | Nascobal |
| E.R. Squibb & Sons, L.L.C. | $12.74 | 2022 | |
| Shire North American Group INC | $12.69 | 2019 | |
| Boston Scientific Corporation | $12.50 | 2019 | |
| Stimwave Technologies Incorporated | $8.72 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jan Parrillo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.